V1RD5 Inhibitors
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. Inhibition of these kinases can lead to a decrease in phosphorylation events that are essential for the activation of V1RD5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. PI3K signaling is crucial for many cellular processes, and inhibition by LY294002 can prevent activation of downstream targets, potentially reducing the activity of V1RD5. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is a part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can prevent the phosphorylation and activation of ERK, which may be necessary for the full activation of V1RD5. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a specific inhibitor of mTOR, which is part of the PI3K/AKT/mTOR pathway. Inhibition of mTOR can downregulate protein synthesis and other processes that could be crucial for the activity of V1RD5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which can block the PI3K/AKT signaling pathway. This blockade can suppress the activation of downstream proteins, potentially including V1RD5. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is involved in the MAPK signaling pathway. By inhibiting JNK, SP600125 can decrease the activity of transcription factors that might regulate the expression of V1RD5. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. p38 MAP kinase is involved in stress and inflammatory responses, and its inhibition could lead to reduced activation of transcription factors that may influence V1RD5 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which functions upstream of ERK in the MAPK pathway. By inhibiting MEK, U0126 can prevent the activation of ERK and potentially decrease the activity of V1RD5. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK, which is involved in actin cytoskeleton organization. By inhibiting ROCK, Y-27632 can alter cell morphology and signaling, possibly affecting V1RD5 activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. Aurora kinases are involved in cell cycle regulation, and inhibition can disrupt proper cell division and signaling that may be required for V1RD5 function. | ||||||